https://www.potomac.fr/wp-content/uploads/Mediliant-is-Now-Spitrex.png371507François Herviohttps://www.potomac.fr/wp-content/uploads/Potomac.jpgFrançois Hervio2023-06-30 19:40:502023-06-30 19:46:49The Mediliant Group, has announced its rebrand to SpiTrex Orthopedics
https://www.potomac.fr/wp-content/uploads/Lorcos-actualité-image.png208384François Herviohttps://www.potomac.fr/wp-content/uploads/Potomac.jpgFrançois Hervio2023-06-06 16:36:562023-08-22 16:41:22Potomac advises Ekkio Capital on the acquisition of solid cosmetics specialist Lorcos to create a leader in natural and responsible cosmetics production
https://www.potomac.fr/wp-content/uploads/IRSS-image-2.jpg506720François Herviohttps://www.potomac.fr/wp-content/uploads/Potomac.jpgFrançois Hervio2023-03-17 10:44:162023-05-15 10:53:47Potomac Transactions advises Ekkio Capital, on its investment in IRSS
https://www.potomac.fr/wp-content/uploads/Logo-Rodael.png4001232François Herviohttps://www.potomac.fr/wp-content/uploads/Potomac.jpgFrançois Hervio2023-02-07 10:56:432023-05-15 10:57:48Potomac advises Herbarom Group in the acquisition of Laboratoires Rodael, a nutraceutical and pharmaceutical CDMO
https://www.potomac.fr/wp-content/uploads/Atlantic-Nature-logo.png199635François Herviohttps://www.potomac.fr/wp-content/uploads/Potomac.jpgFrançois Hervio2022-10-24 16:28:182023-05-15 11:07:53Potomac advises the shareholder re-organisation of Atlantic Nature, a French leader in eco-responsible phytotherapy, financed by the private equity firms IDIA, UNEXO and BNPP